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Résumé en
anglais
4-methyl-N-ethcathinone (4-MEC), the N-ethyl homologue of mephedrone, is a novel
psychoactive substance of the beta-keto amphetamine (cathinone) group. The aim of
the present work was to study the phase I and phase II metabolism of 4-MEC in
human urine as well as in pooled human liver microsome (pHLM) incubations. The
urine samples were worked up with and without enzymatic cleavage, the pHLM
incubations by simple deproteinization. The metabolites were separated and
identified by gas chromatography-mass spectrometry (GC-MS) and liquid
chromatography-high resolution-tandem mass spectrometry (LC-HR-MS/MS). Based
on the metabolites identified in urine and/or pHLM, the following metabolic
pathways could be proposed: reduction of the keto group, N-deethylation,
hydroxylation of the 4-methyl group followed by further oxidation to the
corresponding 4-carboxy metabolite, and combinations of these steps.
Glucuronidation could only be observed for the hydroxy metabolite. These pathways
were similar to those described for the N-methyl homologue mephedrone and other
related drugs. In pHLM, all phase I metabolites with the exception of the N-deethyl-
dihydro isomers and the 4-carboxy-dihydro metabolite could be confirmed.
Glucuronides could not be formed under the applied conditions. Although the taken
dose was not clear, an intake of 4-MEC should be detectable in urine by the GC-MS
and LC-MS(n) standard urine screening approaches at least after overdose.
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